Financial Times interview with the head of the US Food and Drug Administration, Stephen Hahn.
- said his agency was prepared to authorise a vaccine before Phase Three clinical trials were complete
- as long as officials believed the benefits outweighed the risks
Insisted the FDA was not rushing the process to boost Mr Trump's re-election prospects
Article is here for more from hahaHahn